Mar 3, 2026 08:00AM
Feb 26, 2026 08:00AM
Jan 13, 2026 08:00AM
Dec 24, 2025 08:00AM
Dec 24, 2025 08:00AM
Dec 22, 2025 07:06AM
Nov 20, 2025 08:00AM Edgewise Therapeutics adds Christopher Martin to board of directors
Nov 20, 2025 08:00AM
Nov 10, 2025 08:01AM
Nov 10, 2025 08:00AM
Nov 6, 2025 08:00AM
Oct 2, 2025 08:00AM
Sep 11, 2025 08:18AM
Aug 8, 2025 08:43AM Edgewise Therapeutics (EWTX) PT Raised to $49 at RBC Capital
Aug 7, 2025 10:44AM
Aug 7, 2025 08:00AM
Jul 3, 2025 10:00AM
Jul 1, 2025 10:00AM
Jun 28, 2025 10:00AM
Jun 26, 2025 10:32AM
Jun 26, 2025 06:00AM Edgewise Therapeutics Inc. (EWTX) Reports Positive Results on Sevasemten Program
Jun 26, 2025 06:00AM
Jun 11, 2025 08:35AM
Jun 5, 2025 08:53AM
May 8, 2025 08:00AM
Mar 11, 2025 08:00AM
Mar 10, 2025 09:44AM
Mar 3, 2025 08:00AM Edgewise Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Jan 13, 2025 12:50PM
Jan 13, 2025 08:00AM
Jan 2, 2025 12:51PM
Dec 16, 2024 06:05AM
Dec 16, 2024 06:00AM
Dec 5, 2024 02:32PM
Dec 5, 2024 02:32PM Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research
Dec 5, 2024 01:02PM
May 9, 2024 08:00AM
Apr 23, 2024 08:02AM
Apr 23, 2024 08:00AM
Apr 15, 2024 04:06PM
Apr 15, 2024 04:05PM
Feb 22, 2024 08:00AM Edgewise Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Feb 13, 2024 08:02AM
Feb 13, 2024 08:00AM
Jan 9, 2024 08:39AM
Nov 30, 2023 08:06AM
Nov 30, 2023 08:00AM
Nov 9, 2023 08:00AM
Oct 26, 2023 08:03AM Edgewise Therapeutics (EWTX) Announces Expansion of their EDG-5506 Clinical Program in Duchenne Muscular Dystrophy
Oct 26, 2023 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All